Overview

Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Study has been completed and is in the data analysis and manuscript writing phase of the project.
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Medtronic
Treatments:
Calcium heparin
Heparin